Posted On: 04/28/2016 9:02:37 AM
Post# of 72447
New write up on $CTIX.
Osteoarthritis Pipeline Market H1 2016 Global Review Report
2:00 am ET April 28, 2016 (PR Newswire) Print
New market research titled "Osteoarthritis - Pipeline Review, H1 2016" is a report that provides an overview of the Osteoarthritis's therapeutic pipeline and helps strengthen R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Company Profiles discussed in this H1 2016 Osteoarthritis Pipeline report include A. Menarini Industrie Farmaceutiche Riunite Srl, AbbVie Inc., Abiogen Pharma S.p.A., Ablynx NV, Achelios Therapeutics, Inc., Addex Therapeutics Ltd, Akari Therapeutics, Plc, Amura Holdings Limited, Arcarios BV, Asahi Kasei Pharma Corp., Asklepios BioPharmaceutical, Inc., Astellas Pharma Inc., Asterias Biotherapeutics, Inc., Axsome Therapeutics, Inc., Biopharm GmbH, Can-Fite BioPharma Ltd., Cara Therapeutics, Inc., Cardax Pharmaceuticals, Inc., Cellceutix Corporation, Cellular Biomedicine Group, Inc., Chong Kun Dang Pharmaceutical Corp., D
Osteoarthritis Pipeline Market H1 2016 Global Review Report
2:00 am ET April 28, 2016 (PR Newswire) Print
New market research titled "Osteoarthritis - Pipeline Review, H1 2016" is a report that provides an overview of the Osteoarthritis's therapeutic pipeline and helps strengthen R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Company Profiles discussed in this H1 2016 Osteoarthritis Pipeline report include A. Menarini Industrie Farmaceutiche Riunite Srl, AbbVie Inc., Abiogen Pharma S.p.A., Ablynx NV, Achelios Therapeutics, Inc., Addex Therapeutics Ltd, Akari Therapeutics, Plc, Amura Holdings Limited, Arcarios BV, Asahi Kasei Pharma Corp., Asklepios BioPharmaceutical, Inc., Astellas Pharma Inc., Asterias Biotherapeutics, Inc., Axsome Therapeutics, Inc., Biopharm GmbH, Can-Fite BioPharma Ltd., Cara Therapeutics, Inc., Cardax Pharmaceuticals, Inc., Cellceutix Corporation, Cellular Biomedicine Group, Inc., Chong Kun Dang Pharmaceutical Corp., D
(0)
(0)
